REPL::Rights::Voluntary

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Security
IX BIOPHARMA LTD. - SG1BD9000009 - 42C

Announcement Details

Announcement Title
Outcome of Regulatory Review
Date &Time of Broadcast
14-Jun-2016 17:43:57
Status
Replacement
Corporate Action Reference
SG160527RHDIN3O1
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Event Status
Pending AIP/ LQN Announcement
Underwritten
No
Shareholders' Approval Required?
No
Shareholders' Approval Obtained
No
Financial Year End
30/06/2016
Foreign Shareholder Eligibility
No
Attachment for Intent
iX Biopharma - Launch of Rights Issue Announcement.pdf

Regulatory Outcome

Attachment For Regulatory Outcome
iX - Receipt of LQN Announcement.pdf

Event Narrative

Narrative Type
Narrative Text
Additional TextPROPOSED RENOUNCEABLE NON-UNDERWRITTEN RIGHTS ISSUE OF UP TO 24,584,284 NEW ORDINARY SHARES IN THE CAPITAL OF IX BIOPHARMA LTD.

Dates

Rights Details

Security Not Found?
No
Renounceable
Yes
Rights Security Distribution Ratio- Underlying
25
Rights Security Distribution Ratio- Rights Security
1

Option Exercise

Issue Price (Per Rights)
SGD 0.21
Disbursed Security
ISIN
Name
Security Type
Distribution Ratio- Rights
Distribution Ratio- Disbursed
SG1BD9000009IX BIOPHARMA LTD.Ordinary Share11

Renounceable Conditions

Allow Over Subscription
Yes

Attachments

Related Announcements